Timothy P. Zannes - 04 Apr 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Secretary, EVP, Gen. Counsel
Signature
/s/ Maria Zannes, as attorney-in-fact for Timothy P. Zannes
Issuer symbol
BIAF
Transactions as of
04 Apr 2024
Transactions value $
$324
Form type
4
Filing time
24 Apr 2024, 16:00:23 UTC
Previous filing
02 Feb 2024
Next filing
14 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Options Exercise $75.2K +64.8K +629.16% $1.16 75.2K 04 Apr 2024 Direct
transaction BIAF Common Stock Tax liability -$74.9K -29K -38.63% $2.58 46.1K 04 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIAF Stock Option (right to buy) Options Exercise $0 -64.8K -100% $0.00* 0 04 Apr 2024 Common Stock 64.8K $1.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover the exercise price of the options exercised.
F2 This option vested in 7 equal monthly installments beginning on April 28, 2014.